Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma

Hiroyuki Takada, Soichiro Ibaragi, Takanori Eguchi, Tatsuo Okui, Kyoichi Obata, Masanori Masui, Ayaka Morisawa, Kiyofumi Takabatake, Hotaka Kawai, Norie Yoshioka, Nur Mohammad Monsur Hassan, Tsuyoshi Shimo, Guo Fu Hu, Hitoshi Nagatsuka, Akira Sasaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Head and neck squamous cell carcinomas (HNSCCs) frequently invade the bones of the facial skeleton. Semaphorin 4D (Sema4D) is an axon guidance molecule produced by oligodendrocytes. Sema4D was also identified in the bone microenvironment and many cancer tissues including HNSCC. To date, however, the role of Sema4D in cancer-associated bone disease is still unknown. This is the first study to demonstrate the role of Sema4D in bone invasion of cancer. In the clinical tissue samples of bone lesion of HNSCC, Sema4D was detected at high levels, and its expression was correlated with insulin-like growth factor-I (IGF-I) expression. In vitro experiments showed that IGF-I regulates Sema4D expression and Sema4D increased proliferation, migration and invasion in HNSCC cells. Sema4D also regulated the expression of receptor activator of nuclear factor κβ ligand (RANKL) in osteoblasts, and this stimulated osteoclastgenesis. Fur thermore, knockdown of Sema4D in HNSCC cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.

Original languageEnglish
Pages (from-to)625-632
Number of pages8
JournalInternational Journal of Oncology
Volume51
Issue number2
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Bone and Bones
Insulin-Like Growth Factor I
Bone Neoplasms
CD100 antigen
Carcinoma, squamous cell of head and neck
Facial Bones
Tumor Microenvironment
Bone Diseases
Oligodendroglia
Osteoclasts
Cytoplasmic and Nuclear Receptors
Osteoblasts
Heterografts
Osteogenesis
Skeleton
Ligands
Growth
Neoplasms

Keywords

  • Bone invasion
  • Head and neck squamous cell carcinoma
  • Insulin-like growth factor-I
  • Osteoclastogenesis
  • Plexin-B1
  • Semaphorin 4D

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma. / Takada, Hiroyuki; Ibaragi, Soichiro; Eguchi, Takanori; Okui, Tatsuo; Obata, Kyoichi; Masui, Masanori; Morisawa, Ayaka; Takabatake, Kiyofumi; Kawai, Hotaka; Yoshioka, Norie; Hassan, Nur Mohammad Monsur; Shimo, Tsuyoshi; Hu, Guo Fu; Nagatsuka, Hitoshi; Sasaki, Akira.

In: International Journal of Oncology, Vol. 51, No. 2, 01.08.2017, p. 625-632.

Research output: Contribution to journalArticle

Takada, Hiroyuki ; Ibaragi, Soichiro ; Eguchi, Takanori ; Okui, Tatsuo ; Obata, Kyoichi ; Masui, Masanori ; Morisawa, Ayaka ; Takabatake, Kiyofumi ; Kawai, Hotaka ; Yoshioka, Norie ; Hassan, Nur Mohammad Monsur ; Shimo, Tsuyoshi ; Hu, Guo Fu ; Nagatsuka, Hitoshi ; Sasaki, Akira. / Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma. In: International Journal of Oncology. 2017 ; Vol. 51, No. 2. pp. 625-632.
@article{92e015e36c3543f4987c66578f338a9d,
title = "Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma",
abstract = "Head and neck squamous cell carcinomas (HNSCCs) frequently invade the bones of the facial skeleton. Semaphorin 4D (Sema4D) is an axon guidance molecule produced by oligodendrocytes. Sema4D was also identified in the bone microenvironment and many cancer tissues including HNSCC. To date, however, the role of Sema4D in cancer-associated bone disease is still unknown. This is the first study to demonstrate the role of Sema4D in bone invasion of cancer. In the clinical tissue samples of bone lesion of HNSCC, Sema4D was detected at high levels, and its expression was correlated with insulin-like growth factor-I (IGF-I) expression. In vitro experiments showed that IGF-I regulates Sema4D expression and Sema4D increased proliferation, migration and invasion in HNSCC cells. Sema4D also regulated the expression of receptor activator of nuclear factor κβ ligand (RANKL) in osteoblasts, and this stimulated osteoclastgenesis. Fur thermore, knockdown of Sema4D in HNSCC cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.",
keywords = "Bone invasion, Head and neck squamous cell carcinoma, Insulin-like growth factor-I, Osteoclastogenesis, Plexin-B1, Semaphorin 4D",
author = "Hiroyuki Takada and Soichiro Ibaragi and Takanori Eguchi and Tatsuo Okui and Kyoichi Obata and Masanori Masui and Ayaka Morisawa and Kiyofumi Takabatake and Hotaka Kawai and Norie Yoshioka and Hassan, {Nur Mohammad Monsur} and Tsuyoshi Shimo and Hu, {Guo Fu} and Hitoshi Nagatsuka and Akira Sasaki",
year = "2017",
month = "8",
day = "1",
doi = "10.3892/ijo.2017.4050",
language = "English",
volume = "51",
pages = "625--632",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma

AU - Takada, Hiroyuki

AU - Ibaragi, Soichiro

AU - Eguchi, Takanori

AU - Okui, Tatsuo

AU - Obata, Kyoichi

AU - Masui, Masanori

AU - Morisawa, Ayaka

AU - Takabatake, Kiyofumi

AU - Kawai, Hotaka

AU - Yoshioka, Norie

AU - Hassan, Nur Mohammad Monsur

AU - Shimo, Tsuyoshi

AU - Hu, Guo Fu

AU - Nagatsuka, Hitoshi

AU - Sasaki, Akira

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Head and neck squamous cell carcinomas (HNSCCs) frequently invade the bones of the facial skeleton. Semaphorin 4D (Sema4D) is an axon guidance molecule produced by oligodendrocytes. Sema4D was also identified in the bone microenvironment and many cancer tissues including HNSCC. To date, however, the role of Sema4D in cancer-associated bone disease is still unknown. This is the first study to demonstrate the role of Sema4D in bone invasion of cancer. In the clinical tissue samples of bone lesion of HNSCC, Sema4D was detected at high levels, and its expression was correlated with insulin-like growth factor-I (IGF-I) expression. In vitro experiments showed that IGF-I regulates Sema4D expression and Sema4D increased proliferation, migration and invasion in HNSCC cells. Sema4D also regulated the expression of receptor activator of nuclear factor κβ ligand (RANKL) in osteoblasts, and this stimulated osteoclastgenesis. Fur thermore, knockdown of Sema4D in HNSCC cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.

AB - Head and neck squamous cell carcinomas (HNSCCs) frequently invade the bones of the facial skeleton. Semaphorin 4D (Sema4D) is an axon guidance molecule produced by oligodendrocytes. Sema4D was also identified in the bone microenvironment and many cancer tissues including HNSCC. To date, however, the role of Sema4D in cancer-associated bone disease is still unknown. This is the first study to demonstrate the role of Sema4D in bone invasion of cancer. In the clinical tissue samples of bone lesion of HNSCC, Sema4D was detected at high levels, and its expression was correlated with insulin-like growth factor-I (IGF-I) expression. In vitro experiments showed that IGF-I regulates Sema4D expression and Sema4D increased proliferation, migration and invasion in HNSCC cells. Sema4D also regulated the expression of receptor activator of nuclear factor κβ ligand (RANKL) in osteoblasts, and this stimulated osteoclastgenesis. Fur thermore, knockdown of Sema4D in HNSCC cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.

KW - Bone invasion

KW - Head and neck squamous cell carcinoma

KW - Insulin-like growth factor-I

KW - Osteoclastogenesis

KW - Plexin-B1

KW - Semaphorin 4D

UR - http://www.scopus.com/inward/record.url?scp=85021837917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021837917&partnerID=8YFLogxK

U2 - 10.3892/ijo.2017.4050

DO - 10.3892/ijo.2017.4050

M3 - Article

VL - 51

SP - 625

EP - 632

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -